Skip to content

A Study of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha Aashchyotan 2drops four times a day In Kaphabhishyanda with special reference To Simple Allergic conjunctivitis.

A Randomized Controlled Clinical Study Of Efficacy Of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha Aashchyotan in Kaphabhishyanda With Special Reference To Simple Allergic conjunctivitis. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094885
Enrollment
33
Registered
2025-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

vdswapnali ramesh patekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients with signs and symptoms of Simple Allergic conjunctivitis /Kaphabhishyanda. - Patient of 10 to 50 years age group of either gender. - Patients willing for Treatment. - Uncomplicated Simple Allergic Con

Exclusion criteria

Exclusion criteria: Associated with other forms of allergic conditions like skin rash, allergic bronchitis, Atopic and systemic allergic problems. - Cases complicated with superadded infections and corneal ulcers. - Patients not willing for treatment. - Other active infectious systemic disorders / Ophthalmic disord

Design outcomes

Primary

MeasureTime frame
To study the role of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha Aashchyotan in Kaphabhishyanda With Special Reference To Simple Allergic conjunctivitis.Timepoint: 14 days

Secondary

MeasureTime frame
To reduce symptoms of simple allergic conjunctivitis. To establish the efficacy of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha Aashchyotan in Kaphabhishyanda.Timepoint: 14 days

Countries

India

Contacts

Public ContactDrN A KHAN

Government Ayurvedic College And Hospital Nanded

dr.khan_na@yahoo.com9325607099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026